Author

John J. Marshall

Brown UniversityORCID 0000-0002-9937-0268Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

John J. Marshall1 paper · Northwestern University

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Mandar T. NaikiD· 1 shared Nandita M. Naik· 1 shared Sonia Mayoral· 1 shared Szu‐Huan WangiD· 1 shared Xin YangiD· 1 shared Ye HuiD· 1 shared Yong-Hui JiangiD· 1 shared Yu‐Wen Alvin HuangiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Mandar T. NaikORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintMay 21, 2026

Targeting UBE3A and downstream estrogen receptor-β signaling to restore oligodendroglial homeostasis in Angelman syndrome

Xin Yang, Sonia Mayoral, Yong-Hui Jiang…·Yu‐Wen Alvin Huang

The paper identifies UBE3A-dependent regulation of oligodendroglial homeostasis via estrogen receptor-β signaling as a therapeutic target for Angelman syndrome.

1 citation

humanexperimental assay

𝕏 PostBluesky

Molecular BiologyFEBS LettersPeer-reviewedOct 31, 2023

Structure-based development of new cyclic compoundstargeting PSD-95 PDZ3 domain.

Mandar T. Naik, Nandita M. Naik, Ye Hu…·John J. Marshall

The paper develops new cyclic compounds targeting the PSD-95 PDZ3 domain through structure-based design, achieving up to 7-fold stronger affinity than a prototype compound.

8 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky